Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-38,886
Closed -$1.83M 25
2015
Q3
$1.83M Sell
38,886
-25
-0.1% -$1.33K 0.23% 24
2015
Q2
$2.11M Sell
38,911
-58,015
-60% -$3.25M 0.2% 42
2015
Q1
$5.32M Buy
96,926
+4,396
+5% +$249K 0.45% 28
2014
Q4
$5.01M Buy
+92,530
New +$5.16M 0.4% 33
2014
Q3
Sell
-35,190
Closed -$1.94M 282
2014
Q2
$1.94M Buy
35,190
+28,975
+466% +$1.58M 0.21% 33
2014
Q1
$337K Buy
6,215
+1,198
+24% +$62K 0.03% 119
2013
Q4
$240K Sell
5,017
-34,284
-87% -$1.57M 0.02% 314
2013
Q3
$1.78M Buy
39,301
+11,891
+43% +$543K 0.14% 125
2013
Q2
$1.22M Buy
+27,410
New +$1.22M 0.11% 161

Other funds holding MRK

Maple Securities USA's MRK Position: Q4 2015 in Review

Maple Securities USA sold out of Merck (MRK) in Q4 2015, closing a stake of 38,886 shares — an estimated $1.83M sold.

Maple Securities USA first reported a position in MRK in Q2 2013 and held it in 9 quarters. The position peaked at $5.32M in Q1 2015. 1,754 funds tracked by Wall St. Rank hold MRK as of Q4 2015.

  • Maple Securities USA reported no remaining Merck position as of Q4 2015 after selling out during the quarter.
  • Maple Securities USA sold 38,886 Merck shares in Q4 2015, an estimated $1.83M.
  • Maple Securities USA first reported a position in Merck in Q2 2013 and held it in 9 quarters.
  • Maple Securities USA's Merck position peaked at $5.32M in Q1 2015.
  • 1,754 funds tracked by Wall St. Rank held Merck as of Q4 2015.

Based on Maple Securities USA's 13F filing for Q4 2015, filed 15 Jan 2016.